FDA authorizes J&J's one-shot coronavirus vaccine

Bio Pharma Dive

The agency's emergency clearance makes J&J's vaccine the third available in the U.S., adding much-needed reinforcements at a critical time

The true cost of COVID-19?

World of DTC Marketing

SUMMARY: COVID-19 has killed many people worldwide, but how many really died from COVID, and how many died because they had an underlying chronic health problem as a major factor? We may never know, but we can not afford to do anything while our population becomes more obese and unhealthy.


Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Navigating the Global NHP Shortage: How to Keep Your Development Program on Track


In the first half of 2020 and as a direct consequence of the ongoing pandemic, China issued a ban on the export of non-human primates (NHPs) , including those used for pharmaceutical research.

Climate impacts drive east-west divide in forest seed production


Western forests may be less able to regenerate following large-scale diebacks Credit: USGS DURHAM, N.C.

Johnson & Johnson Will Test its Vaccine in Infants

NY Times

The company’s coming trials will also involve pregnant women and people whose immune systems are compromised. internal-essential Children and Childhood Coronavirus (2019-nCoV) Drugs (Pharmaceuticals) Immune System Clinical Trials Vaccination and Immunization Babies and Infants Johnson & Johnson

Need Health Insurance? Marketplaces are Open Now!

Triage Cancer

Health Insurance Marketplaces are now open for a Special Enrollment Period (SEP). In the 36 states with Marketplaces on www.HealthCare.gov, individuals have the opportunity to buy a new health insurance policy or change policies until May 15, 2021.


Pfizer/BioNTech to trial COVID-19 vaccine in pregnant women and children

BioPharma Reporter

Pfizer and BioNTech have dosed the first participants in a Phase 2/3 study for their COVID-19 vaccine in pregnant women; and plan to trial the vaccine in children later this year. Bio Developments

Trials 114

More Trending

Disney characters will lend a hand to kids during MRI scans

Pharma Phorum

Radiologists in Europe could soon have help keeping children calm as they have MRI scans from Disney favourites like Micky Mouse, Winnie the Pooh and the Little Mermaid.

Over-the-Counter Nasal Spray Could Be Effective Against COVID-19


An in vitro study conducted by scientists from Northwestern University and Utah State University concluded that components found within the Xlear nasal spray, particularly grapefruit seed extract and xylitol, were successful in statistically reducing the amount of SARS-CoV-2 in a patient

ERT Imaging Accelerates Ground-Breaking Research to Improve the Development of Oncology and CNS Treatments


Blue Earth Diagnostics utilizing ERT imaging solution to evaluate a novel imaging agent for potential use to inform brain metastases disease management.

Bristol Myers finally wins FDA approval for cancer cell therapy

Bio Pharma Dive

Delays tied to factory inspections had pushed an FDA decision on Breyanzi past a key deadline, allowing Bristol Myers to avoid paying billions of dollars in payouts to investors

The health care industry should also invest more preventative health

World of DTC Marketing

SUMMARY: In a recent study by The Harris Poll on behalf of TIME, the overwhelming majority of Americans (78%) admitted to delaying routine medical services and health care appointments due to the coronavirus pandemic.

Neurology’s Growing Need for Disposable Technologies

Pharma Mirror

By Boris Goldstein, Co-Founder & Executive Chairman at Brain Scientific COVID-19 is known for its impacts on a patient’s respiratory system, but it has also been found to affect individuals in unique ways and with varying severity levels depending on their age, risk factors, and comorbidities.

How to harness artificial intelligence to boost business and make our world more human


Welcome to the World of Hyperautomation Credit: World Scientific Two centuries ago, the Industrial Revolution began to automate “blue-collar” work, allowing higher profits and wider societal improvements like the reduction of famine and the increase in living standards.

Pfizer Will Ship Fewer Covid-19 Vaccine Vials to Account for ‘Extra’ Doses

NY Times

After the surprise discovery of an extra dose in every vial, Pfizer executives successfully lobbied the F.D.A. to change the vaccine’s formal authorization language. The company charges by the dose.

FDA Says Data Does Not Support Changes to COVID-19 Vaccine Doses


The US Food and Drug Administration (FDA) released a statement this week about dosing schedules for COVID-19 vaccines, saying that any dose changes would be premature.

WHO weighs in on COVID-19 vaccine second dose delay

BioPharma Reporter

The World Health Organizationâs vaccine advisory group recommends the two doses of the Pfizer/BioNTech vaccine should be delivered 21 to 28 days apart: although it adds that the maximum time period between doses could be up to six weeks in some situations. Markets & Regulations

Colorado RFP on Drug Importation Accounts for Canada’s Order Protecting Against Shortages

Pharmacy Checkers

This week, the Colorado Department of Health Care Policy and Financing issued a request for proposals, called an Invitation to Negotiate, to operate a state wholesale drug importation program as permitted under federal law and the administrative final rule issued by HHS last year, referred to as the Section 804 rule.

How accidental advocacy is amplifying the GM1 voice

Pharma Phorum

Rare disease families need to stand up and be counted if they want things to change said mum and advocate Christine Waggoner. She spoke to pharmaphorum as part of our Patients Insights series. Like many “rare disease mums”, Christine is an accidental advocate.

COVID-19 Long-Hauler Therapy Space Beginning to Take Shape


While the space is just beginning to emerge, therapies for long-haul COVID-19 patients are still very much an unmet need


Boehringer Ingelheim announces partnership with Google

Pharma Times

Partnership will aim to research and implement quantum computing in pharma R&D

As COVID-19 becomes a business, vaccine makers confront thorny pricing questions

Bio Pharma Dive

Yearly vaccinations could be required after the pandemic ebbs. Will drugmakers change how they approach pricing their shots

As pharma abandons the antibiotic market patients are at risk

World of DTC Marketing

SUMMARY: According to Pew Internet “Despite antibiotics’ vital role in cancer care, companies have abandoned their development in favor of more profitable drugs.

5 Trends That Will Shape Pharma Marketing in 2021

Pharma Marketing Network

Throughout the year 2020, pharma marketers were forced to explore new strategies in order to keep up with the many evolving trends. Pharma marketers have quickly learned how to adapt to these trends and are prepared to take on new opportunities in 2021.

Origami with DNA


A team at TU Wien was able to answer important questions about the immune system – with a trick reminiscent of paper folding. Credit: TU Wien T-cells are an important component of our immune system: with the receptors they carry on their surface, they can recognise highly specific antigens.

DNA 85

Alzheimer’s Drug Shows Promise in Small Trial

NY Times

Participants with the disease still declined, but much more slowly than those receiving a placebo, investigators say. Alzheimer's Disease Clinical Trials Drugs (Pharmaceuticals) Brain Eli Lilly and Company donanemab

Trials 114

Thrombocytopenia Drugs Market: What Newer Agents Are Expected To Enter The Market?


The launch of a novel drug in the market is not less than a celebration in the pharmaceutical and healthcare market; however, it also brings the real challenge of sustenance in the market. Similar is the picture of the Thrombocytopenia Drugs Market.

'Vaccines are working': UK unveils real-world data from vaccination campaign

BioPharma Reporter

Real-world data from England shows that the Pfizer/BioNTech vaccine offers 'clear protection from first dose' and may help interrupt transmission; while Scottish data shows the first doses of vaccines led to a substantial fall in hospital admissions. Bio Developments

State Drug Importation Bills Just Got More Personal in California

Pharmacy Checkers

With lies and deception, Big Pharma has used the threat posed by rogue websites and counterfeit drugs to push back against U.S. state legislation to gain access to lower drug prices in Canada.

A new approach to COVID-19 treatment

Pharma Phorum

While pharma has raced to develop COVID-19 vaccines, US-based company NeuroRx is taking a different approach to treating the virus.

University of Oregon Campus Could Be Cornerstone of New Biotech Hotspot


A new biotech hotspot could be on the horizon in Oregon thanks to a $500 million gift to the University of Oregon from Nike co-founder Phil Knight, an alumnus of the university


CRUK scientists develop drug that targets KRAS pathways

Pharma Times

KRAS mutations are found in several hard-to-treat cancers

Gene therapy for hemophilia: So close, yet so far away

Bio Pharma Dive

Significant setbacks for pace-setting programs from BioMarin and UniQure have renewed questions about gene therapy’s promise, and its safety

And just like that, the goodwill is gone

World of DTC Marketing

THOUGHT: The reports of “pharma goodwill” were premature.

Sales 180

Why Mask-Associated Dry Eye Won’t Necessarily Boost Restasis Sales


Dry eye disease may sound innocuous, but it’s a condition that affects between 25 and 35 percent of individuals in the US, and pandemic-related lifestyle changes may be pushing that percentage up.

Sales 92

Researchers find peptide that treats, prevents killer citrus disease


Treatment causes deadly bacterium to leak and die Credit: Hailing Jin/UCR New research affirms a unique peptide found in an Australian plant can destroy the No. 1 killer of citrus trees worldwide and help prevent infection.

One and Done: Why People Are Eager for Johnson & Johnson’s Vaccine

NY Times

Johnson & Johnson’s one-shot vaccine is allowing states to rethink distribution, even as health officials and experts worry some will view it as inferior.